Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for Prevention of Neurologic Altitude Sickness in Marines
NCT01606527Phase 2Unknown
- Sponsor
- Naval Health Research Center
- Start
- Jul 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in Altitude sickness (AMS), sponsored by Naval Health Research Center. Status: unknown.
02
Drugs
ibuprofen
03
Conditions
Altitude sickness (AMS)
Beyond the preview
Go deeper on NCT01606527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606527.